Cargando…
The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial
A major obstacle to the development of new treatments for venous leg ulcers is the difficulty in generating evidence for their effectiveness. Randomised controlled trials using complete healing as the endpoint are seldom powered to be successful, owing to the heterogeneity of cohorts. A novel approa...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333027/ https://www.ncbi.nlm.nih.gov/pubmed/36785909 http://dx.doi.org/10.1111/iwj.14107 |
_version_ | 1785070565431705600 |
---|---|
author | Bull, Richard Hillson Clements, Donna Collarte, Agnes Juguilon Harding, Keith Gordon |
author_facet | Bull, Richard Hillson Clements, Donna Collarte, Agnes Juguilon Harding, Keith Gordon |
author_sort | Bull, Richard Hillson |
collection | PubMed |
description | A major obstacle to the development of new treatments for venous leg ulcers is the difficulty in generating evidence for their effectiveness. Randomised controlled trials using complete healing as the endpoint are seldom powered to be successful, owing to the heterogeneity of cohorts. A novel approach to the evaluation of treatments is presented, using a self‐controlled trial model and two metrics of short‐term healing rate as alternate endpoints: rate of wound margin advance, and percentage area reduction over 4 weeks. Two different treatment regimens are compared: multi‐layer compression alone, versus multi‐layer compression combined with activation of the venous leg pump by neuromuscular stimulation. With 60 patients, adding neuromuscular stimulation to multilayer compression resulted in a significant two‐fold increase in the rate of wound healing over a 4‐week period, both in terms of wound margin advance and in terms of percentage area reduction. The use of these short‐term intermediate endpoint metrics together with a self‐controlled study design offers potential for distinguishing between the relative efficacies of interventions more rapidly, with greater sensitivity, and with fewer subjects than a conventional RCT cohort model. |
format | Online Article Text |
id | pubmed-10333027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-103330272023-07-12 The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial Bull, Richard Hillson Clements, Donna Collarte, Agnes Juguilon Harding, Keith Gordon Int Wound J Original Articles A major obstacle to the development of new treatments for venous leg ulcers is the difficulty in generating evidence for their effectiveness. Randomised controlled trials using complete healing as the endpoint are seldom powered to be successful, owing to the heterogeneity of cohorts. A novel approach to the evaluation of treatments is presented, using a self‐controlled trial model and two metrics of short‐term healing rate as alternate endpoints: rate of wound margin advance, and percentage area reduction over 4 weeks. Two different treatment regimens are compared: multi‐layer compression alone, versus multi‐layer compression combined with activation of the venous leg pump by neuromuscular stimulation. With 60 patients, adding neuromuscular stimulation to multilayer compression resulted in a significant two‐fold increase in the rate of wound healing over a 4‐week period, both in terms of wound margin advance and in terms of percentage area reduction. The use of these short‐term intermediate endpoint metrics together with a self‐controlled study design offers potential for distinguishing between the relative efficacies of interventions more rapidly, with greater sensitivity, and with fewer subjects than a conventional RCT cohort model. Blackwell Publishing Ltd 2023-02-13 /pmc/articles/PMC10333027/ /pubmed/36785909 http://dx.doi.org/10.1111/iwj.14107 Text en © 2023 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Bull, Richard Hillson Clements, Donna Collarte, Agnes Juguilon Harding, Keith Gordon The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial |
title | The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial |
title_full | The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial |
title_fullStr | The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial |
title_full_unstemmed | The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial |
title_short | The impact of a new intervention for venous leg ulcers: A within‐patient controlled trial |
title_sort | impact of a new intervention for venous leg ulcers: a within‐patient controlled trial |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333027/ https://www.ncbi.nlm.nih.gov/pubmed/36785909 http://dx.doi.org/10.1111/iwj.14107 |
work_keys_str_mv | AT bullrichardhillson theimpactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial AT clementsdonna theimpactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial AT collarteagnesjuguilon theimpactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial AT hardingkeithgordon theimpactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial AT bullrichardhillson impactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial AT clementsdonna impactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial AT collarteagnesjuguilon impactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial AT hardingkeithgordon impactofanewinterventionforvenouslegulcersawithinpatientcontrolledtrial |